Thrivent Financial For Lutherans Biocryst Pharmaceuticals Inc Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022
SELL
$11.18 - $15.46 $1.29 Million - $1.78 Million
-115,100 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$14.21 - $17.65 $5,257 - $6,530
-370 Reduced 0.32%
115,100 $1.65 Million
Q2 2021

Aug 19, 2021
BUY
$9.5 - $17.24 $1.1 Million - $1.99 Million
115,470 New
115,470 $1.83 Million

Others Institutions Holding BCRX

# of Institutions
260
Shares Held
173M
Call Options Held
397K
Put Options Held
444K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email